Janus Henderson Group PLC Moderna, Inc. Transaction History

Janus Henderson Group PLC

$187 Billion
Q3 2024

A detailed history of Janus Henderson Group PLC transactions in Moderna, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 40,607 shares of MRNA stock, worth $1.67 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

40,607

Previous 36,907 10.03%

Holding current value

$1.67 Million

Previous $4.38 Million 38.09%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$63.64 - $125.14 $235,468 - $463,018	3,700 Added 10.03%	40,607 $2.71 Million
Q2 2024 Aug 14, 2024	SELL	$101.21 - $166.61 $862,207 - $1.42 Million	-8,519 Reduced 18.75%	36,907 $4.38 Million
Q1 2024 May 15, 2024	SELL	$85.37 - $115.44 $9,134 - $12,352	-107 Reduced 0.23%	45,426 $4.84 Million
Q4 2023 Feb 14, 2024	SELL	$69.51 - $104.43 $26.9 Million - $40.4 Million	-386,480 Reduced 89.46%	45,533 $4.53 Million
Q3 2023 Nov 14, 2023	BUY	$96.41 - $126.61 $3.88 Million - $5.1 Million	40,295 Added 10.29%	432,013 $44.6 Million
Q2 2023 Aug 14, 2023	BUY	$118.5 - $160.53 $40.1 Million - $54.4 Million	338,671 Added 638.44%	391,718 $47.6 Million
Q1 2023 May 15, 2023	BUY	$135.66 - $197.02 $1.26 Million - $1.82 Million	9,252 Added 21.13%	53,047 $8.15 Million
Q4 2022 Feb 14, 2023	SELL	$118.38 - $210.04 $25 Million - $44.4 Million	-211,549 Reduced 82.85%	43,795 $7.87 Million
Q3 2022 Nov 14, 2022	SELL	$118.07 - $194.18 $2.69 Million - $4.43 Million	-22,792 Reduced 8.19%	255,344 $30.2 Million
Q2 2022 Aug 15, 2022	SELL	$117.13 - $176.59 $47 Million - $70.8 Million	-400,978 Reduced 59.04%	278,136 $39.7 Million
Q1 2022 May 16, 2022	SELL	$126.46 - $235.05 $20.1 Million - $37.4 Million	-159,081 Reduced 18.98%	679,114 $117 Million
Q4 2021 Feb 14, 2022	BUY	$225.82 - $368.51 $37.8 Million - $61.7 Million	167,352 Added 24.95%	838,195 $213 Million
Q3 2021 Nov 16, 2021	SELL	$221.9 - $484.47 $112 Million - $245 Million	-505,371 Reduced 42.97%	670,843 $258 Million
Q2 2021 Aug 16, 2021	BUY	$129.91 - $234.98 $84.4 Million - $153 Million	649,446 Added 123.29%	1,176,214 $276 Million
Q1 2021 May 17, 2021	BUY	$109.18 - $185.98 $41.2 Million - $70.2 Million	377,476 Added 252.84%	526,768 $69 Million
Q4 2020 Feb 16, 2021	BUY	$65.74 - $169.86 $2.98 Million - $7.71 Million	45,392 Added 43.69%	149,292 $15.6 Million
Q3 2020 Nov 16, 2020	SELL	$54.34 - $94.85 $41 Million - $71.5 Million	-753,857 Reduced 87.89%	103,900 $7.35 Million
Q2 2020 Aug 14, 2020	BUY	$29.67 - $80.0 $23 Million - $62.1 Million	776,564 Added 956.44%	857,757 $55.1 Million
Q1 2020 May 14, 2020	BUY	$17.78 - $31.58 $1.44 Million - $2.56 Million	81,193 New	81,193 $2.43 Million

Others Institutions Holding MRNA

# of Institutions

952

Shares Held

241M

Call Options Held

10.6M

Put Options Held

18.7M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $16.1B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.

Account

Janus Henderson Group PLC Moderna, Inc. Transaction History